CareDx (CDNA) Liabilities and Shareholders Equity (2013 - 2026)

CareDx has reported Liabilities and Shareholders Equity for 14 years, with the latest figure at $533.0 million in Q2 2026.

• Quarterly Liabilities and Shareholders Equity rose 19.97% year-over-year to $533.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.8 billion (down 5.91% YoY) and the FY2025 annual result came in at $413.2 million, down 15.85% from the prior year.
• Liabilities and Shareholders Equity rose to $533.0 million in Q2 2026 per CDNA's latest filing, from $411.1 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $546.7 million in Q1 2022 and troughed at $411.1 million in Q1 2026.
• A 5-year average of $488.7 million and a median of $490.3 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The widest YoY moves for Liabilities and Shareholders Equity: up 19.97% in 2026, down 16.05% in 2026.
• Over 5 years, Liabilities and Shareholders Equity stood at $543.0 million in 2022, then fell by 14.03% to $466.8 million in 2023, then increased by 5.19% to $491.0 million in 2024, then declined by 15.85% to $413.2 million in 2025, then advanced by 28.98% to $533.0 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $533.0 million, $411.1 million, and $413.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.